Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000863251 | SCV001003881 | likely benign | Charcot-Marie-Tooth disease axonal type 2P | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001173644 | SCV001336746 | uncertain significance | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Gene |
RCV001683673 | SCV001903067 | uncertain significance | not provided | 2020-09-22 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 32376792) |
Ambry Genetics | RCV002415987 | SCV002680306 | uncertain significance | Inborn genetic diseases | 2022-06-07 | criteria provided, single submitter | clinical testing | Unlikely to be causative of autosomal dominant Charcot-Marie-Tooth disease, type 2P (CMT2P) Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |